Video Library

This presentation reviews the latest advances in preventing and treating acute and chronic graft-versus-host disease (GVHD). Dr. Cutler discusses how post-transplant cyclophosphamide (PTCy) has changed GVHD prevention, new treatments for chronic GVHD, and research on combination therapies and early intervention. He also answers questions about clinical trials, treatment duration, and GVHD’s relationship to relapse.

Dr. Issa discusses infection prevention and management after stem cell transplant, focusing on how infection risks change throughout the transplant journey. The presentation covers common bacterial, fungal, and viral infections; the impact of immunosuppression and GVHD; vaccination recommendations; and practical strategies to reduce infection risk.

This presentation describes how changes in memory, thinking, and overall cognitive function feel for patients who experience them, the reasons these changes occur after transplant and CAR T-cell therapy, and strategies to manage them.

This presentation reviews common lung complications after bone marrow transplant or CAR T-cell therapy, including BOS, organizing pneumonia, bronchiectasis, and restrictive lung disease. It also covers early diagnosis, pulmonary function testing, new imaging and treatment options, and ways to help preserve lung function and quality of life.

Graft-versus-host disease (GVHD) is a potential complication after a bone marrow/stem cell transplant using donor cells. This presentation explains what GVHD (GVHD) is, the difference between acute and chronic GVHD, risk factors for developing GVHD, how to monitor yourself to catch and report symptoms early, treatment options, and lifestyle changes that can improve GVHD symptoms.

Dr. Jessica Ciralsky discusses ocular graft-versus-host disease (GVHD), including common symptoms, diagnosis, and treatment. She explains why early detection is important and reviews supportive care, specialized eye care, and emerging approaches for managing ocular GVHD.

Monitoring and maintaining oral health after transplant is an important part of recovery. This presentation describes typical issues with oral health after transplant, including graft-versus-host disease, and how to treat these conditions effectively.

Transplant recipients often experience ongoing issues from their disease and treatment. This presentation describes typical post-transplant complications and how a survivorship plan can help survivors maintain optimal health.

This presentation discusses quality of life after CAR T-cell therapy, potential short-term, late, and long-term side effects, incidence and risk factors for late and long-term side effects, how to monitor yourself for side effects, when and to whom you should report symptoms, and lifestyle changes that can help prevent or manage long-term effects of CAR T-cell therapy.

Bone health is an important part of long-term recovery after bone marrow transplant and CAR T-cell therapy. This presentation explains why transplant recipients are at increased risk for bone loss and fractures, how osteoporosis develops, who should be screened, and what lifestyle changes, nutritional strategies, exercise, and medications can help maintain healthy bones and reduce fracture risk as patients age.

CAR T-cell therapy (chimeric antigen receptor T-cell therapy) is a type of immune therapy that uses the body's own immune system to treat cancer. This presentation describes what’s involved in undergoing CAR T-cell therapy, potential side effects and outcomes, and research underway to treat more diseases and improve outcomes and quality of life for CAR T-cell recipients.

In this session, leading experts on graft-versus-host disease (GVHD), a common complication after a bone marrow/stem cell transplant, respond to questions about who is at risk of developing GVHD, symptoms of GVHD, and how to manage both the physical and emotional problems associated with GVHD and its treatment.